Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Smoldering Multiple Myeloma 2Prostatic Neoplasms 2Monoclonal Gammopathy of Undetermined Significance 2Uterine Cervical Neoplasms 1Thrombocythemia, Essential 1Stomach Neoplasms 1Psychological Well-Being 1Primary Myelofibrosis 1Polycythemia Vera 1Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Motor Activity 1Lung Neoplasms 1Locally Advanced Cervical Cancer 1Esophageal Neoplasms 1Castration Sensitive Prostate Cancer 1

Interventions

venetoclax 27fludarabine 26Cyclophosphamide 25Specimen Handling 20Azacitidine 20Biopsy 15Whole-Body Irradiation 14Cytarabine 14Stem Cell Transplantation 13Decitabine 13Tacrolimus 12Melphalan 12fludarabine phosphate 11Mycophenolic Acid 11Busulfan 11Injections 9X-Rays 7Thiotepa 7Hematopoietic Stem Cell Transplantation 7Granulocyte Colony-Stimulating Factor 7decitabine and cedazuridine drug combination 6Cyclosporine 6ruxolitinib 5Magnetic Resonance Spectroscopy 5Idarubicin 5Filgrastim 5gilteritinib 4Sirolimus 4Peripheral Blood Stem Cell Transplantation 4Cyclosporins 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Myelodysplastic Syndromes × Curcumin × Clear all
NCT06063486 2026-03-27

Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms

University of Southern California

Phase 2 Recruiting
30 enrolled
Myeloid

Myelodysplastic Syndromes, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡